Daily Peptide Research Spotlights: The Ultimate Guide to CJC-1295 NO DAC + Ipamorelin for Synergistic Results

03/01/2026 | Bio Bulk Peptides |

Molecular Specifications and Technical Data

The study of growth hormone secretagogues (GHS) has been significantly advanced by the synthesis of compound blends designed to mimic endogenous hormonal signaling. The combination of CJC-1295 NO DAC and Ipamorelin represents a dual-pathway approach to stimulating the pituitary gland.

CJC-1295 NO DAC (Modified GRF 1-29)

  • Molecular Formula: C152H252N44O42
  • Molecular Weight: 3367.9 g/mol
  • Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
  • Classification: Growth Hormone Releasing Hormone (GHRH) Analog

Ipamorelin

  • Molecular Formula: C38H49N9O5
  • Molecular Weight: 711.85 g/mol
  • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
  • Classification: Selective Growth Hormone Secretagogue Receptor (GHSR) Agonist

Mechanism of Action: The Dual-Signal Pathway

In peptide research, the synergy between CJC-1295 NO DAC and Ipamorelin is characterized by their complementary actions on the anterior pituitary somatotropes. While both compounds target the eventual release of Growth Hormone (GH), they utilize distinct biochemical pathways to achieve a amplified physiological response.

CJC-1295 NO DAC serves as a GHRH mimetic. It binds to the GHRH receptors (GHRHR) in the pituitary gland, stimulating the production and release of GH. This specific version, "NO DAC" (without Drug Affinity Complex), is a modified version of the first 29 amino acids of Growth Hormone Releasing Hormone. The modifications at positions 2, 8, 15, and 27 are designed to increase resistance to dipeptidyl peptidase-4 (DPP-IV) cleavage, thereby extending the biological half-life compared to endogenous GHRH.

Ipamorelin acts as a selective ghrelin receptor agonist. Unlike earlier growth hormone-releasing peptides (GHRPs), Ipamorelin demonstrates high selectivity for the GH secretion pathway without significantly impacting the secretion of cortisol, prolactin, or aldosterone. Its mechanism involves two primary actions: inhibiting the release of somatostatin (a hormone that suppresses GH release) and directly stimulating the GHSR on the pituitary.

When combined, research suggests a 3-5 fold increase in growth hormone release compared to the administration of either peptide in isolation. This synergy is attributed to the simultaneous stimulation of the GHRH receptor and the GHSR, which mimics the natural pulsatile release of GH observed in healthy mammalian models.

Synergistic peptide signaling of CJC-1295 and Ipamorelin targeting the pituitary gland.

Research Applications in Biotechnology and Medicine

The investigation of CJC-1295 NO DAC + Ipamorelin spans various disciplines within biotech and pharmaceutical research. The primary areas of interest include metabolic regulation, tissue regeneration, and cellular longevity.

1. Analysis of Body Composition and Metabolism

Preclinical studies have explored the influence of this peptide combination on adipocytes and skeletal muscle tissue. The increase in circulating GH and subsequent IGF-1 (Insulin-like Growth Factor 1) levels has been associated with:

  • Enhanced Lipolysis: The stimulation of hormone-sensitive lipase leads to the breakdown of stored triglycerides into free fatty acids.
  • Nitrogen Retention: Investigating the compound’s ability to promote a positive nitrogen balance, which is essential for the synthesis of new protein structures.
  • Myocyte Proliferation: Research into how the GH/IGF-1 axis promotes the development of lean muscle mass through the activation of satellite cells.

2. Tissue Repair and Collagen Synthesis

The role of GH in systemic repair mechanisms makes this blend a significant subject of study for musculoskeletal research. Investigations have focused on the accelerated repair of connective tissues, including tendons and ligaments. The mechanism is believed to involve the upregulation of collagen mRNA expression, leading to increased structural integrity in damaged matrices.

3. Cognitive Function and Neuroprotection

Emerging research in the field of neuroscience has begun to investigate the potential neuroprotective effects of growth hormone secretagogues. The presence of GH receptors in the hippocampus suggests that elevated GH levels may influence neuroplasticity, memory retention, and mental processing speed. Furthermore, the impact of these compounds on sleep architecture: specifically the enhancement of slow-wave sleep: is a critical area of study, as this phase of sleep is vital for cellular repair and cognitive restoration.

The Importance of Laboratory Grade Purity

For researchers and biotech professionals, the integrity of experimental data is directly dependent on the purity of the compounds utilized. Biobulkpeptides.com emphasizes the necessity of laboratory grade materials to ensure reproducible results.

Impurities in peptide synthesis, such as truncated sequences, trifluoroacetate (TFA) salts, and residual solvents, can introduce uncontrolled variables into a study. High-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis are required to verify that the CJC-1295 NO DAC + Ipamorelin blend meets a minimum purity threshold of 99%.

Using low-purity peptides may lead to:

  • Inconsistent binding affinity at the receptor site.
  • Unintended cellular responses due to contaminant toxicity.
  • Reduced biological activity, leading to inaccurate dosage-response curves.

Researchers can access verification documentation at biobulkpeptides.com/coa-s to confirm the chemical specifications of the materials.

Laboratory grade vial containing high-purity lyophilized peptide powder for scientific research.

Comparative Half-Life and Stability

A critical distinction in peptide research involves the pharmacokinetics of the CJC-1295 variant. While the Drug Affinity Complex (DAC) version is engineered for a prolonged half-life of several days, the CJC-1295 NO DAC (Modified GRF 1-29) is characterized by a shorter duration of action, typically 30 minutes to 2 hours in various animal models.

However, some research indicates that when properly formulated, the absence of DAC allows for a more controlled "pulse" of growth hormone, which more closely mirrors the natural circadian rhythms of GH secretion. This makes the "NO DAC" variant a preferred choice for researchers investigating acute physiological responses rather than chronic baseline elevations.

Handling and Storage Protocols

To maintain the structural integrity of the lyophilized powder, specific storage conditions must be observed. Peptides are sensitive to temperature fluctuations, UV light, and mechanical agitation.

  • Lyophilized State: Should be stored at -20°C for long-term stability. At 4°C, the compound remains stable for shorter periods (typically 12-24 months).
  • Reconstituted State: Once reconstituted with bacteriostatic water or sterile saline, the compound should be stored at 2°C to 8°C. It is recommended to use the reconstituted material within 14 days to prevent degradation.
  • Handling: Avoid vigorous shaking of the vial. Gentle swirling is sufficient to ensure the peptide enters solution.

Experimental Dosing Considerations

In laboratory environments, dosing protocols are determined based on the specific research objective and the weight of the subject. Common research parameters involve twice-daily administration to capitalize on the synergistic peak of the two compounds. It has been observed in various models that the absence of caloric intake (fasting state) during the time of administration maximizes the pituitary response, as high blood glucose and somatostatin levels can inhibit GH release.

Concluding Research Perspectives

The combination of CJC-1295 NO DAC + Ipamorelin remains a cornerstone of GHS research. Its ability to selectively and powerfully stimulate the endogenous GH axis without significant side effects on other hormonal pathways provides a robust tool for studying metabolic health, cellular repair, and physiological optimization.

For more information on available research materials, visit the biobulkpeptides.com shop.

For Research Use Only.

The materials provided by biobulkpeptides.com are intended strictly for laboratory research purposes. They are not for human or animal consumption. These products are not intended to diagnose, treat, cure, or prevent any disease. All researchers must adhere to local and federal regulations regarding the handling and use of research peptides.

  • Product Name: CJC-1295 NO DAC + Ipamorelin
  • Application: Laboratory Research
  • Standard: Laboratory Grade (99%+ Purity)
  • Shipping: Orders are typically processed and shipped within 24-48 hours.

Disclaimer: This article is for educational and research purposes only. The information provided regarding the mechanisms and applications of CJC-1295 NO DAC and Ipamorelin is derived from existing preclinical data and scientific literature. Biobulk Peptides does not condone the use of these compounds outside of a controlled laboratory setting.

NOT FOR HUMAN USE. FOR RESEARCH PURPOSES ONLY.